The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arulanandam, B. P.
Right arrow Articles by Metzger, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arulanandam, B. P.
Right arrow Articles by Metzger, D. W.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2000, 164: 3698-3704.
Copyright © 2000 by The American Association of Immunologists

Neonatal Administration of IL-12 Enhances the Protective Efficacy of Antiviral Vaccines1

Bernard P. Arulanandam*, James N. Mittler{dagger},{ddagger}, William T. Lee{dagger},{ddagger}, Margot O’Toole§ and Dennis W. Metzger2,*

* Center for Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208; {dagger} Laboratory of Immunology, Wadsworth Center, Albany, NY 12201; {ddagger} Department of Biomedical Sciences, School of Public Health, State University of New York, Albany, NY 12201; and § Genetics Institute, Cambridge, MA 01810

Neonates are highly susceptible to infectious agents and are known to display polarized expression of Th2-like cytokines and Abs. This neonatal immune bias has important implications for the development of vaccine strategies, particularly against viral infections. We now report that coadministration of IL-12 and an influenza subunit vaccine at birth enhances the protective efficacy of antiviral vaccination. Immunization and treatment with IL-12 within 24 h of birth resulted in elevated expression of IFN-{gamma}, IL-10, and IL-15 mRNA in the spleens of newborn mice compared with animals exposed to vaccine only. In addition, these animals showed dramatic increases in IFN-{gamma}-, IL-2-, and IL-4-secreting cells, and in IgG2a Ab levels upon adult challenge compared with mice primed with vaccine alone. Most importantly, animals vaccinated and simultaneously treated with IL-12 at birth displayed enhanced survival after lethal challenge with infectious influenza virus as adults compared with infected animals that had been primed with vaccine alone. This augmented protection required B cells and could be transferred to naive mice by immune serum. Collectively, these results provide evidence that administration of IL-12 to neonates induces a Th1-like response in newborns and elicits protective antiviral immune memory.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Jupelli, M. N. Guentzel, P. A. Meier, G. Zhong, A. K. Murthy, and B. P. Arulanandam
Endogenous IFN-{gamma} Production Is Induced and Required for Protective Immunity against Pulmonary Chlamydial Infection in Neonatal Mice
J. Immunol., March 15, 2008; 180(6): 4148 - 4155.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
X. Zhang, E. Deriaud, X. Jiao, D. Braun, C. Leclerc, and R. Lo-Man
Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells
J. Exp. Med., May 14, 2007; 204(5): 1107 - 1118.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Ma and A. C. Ross
The anti-tetanus immune response of neonatal mice is augmented by retinoic acid combined with polyriboinosinic:polyribocytidylic acid
PNAS, September 20, 2005; 102(38): 13556 - 13561.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Regner, X. Martinez, E. Belnoue, C.-M. Sun, F. Boisgerault, P.-H. Lambert, C. Leclerc, and C.-A. Siegrist
Partial Activation of Neonatal CD11c+ Dendritic Cells and Induction of Adult-Like CD8+ Cytotoxic T Cell Responses by Synthetic Microspheres
J. Immunol., August 15, 2004; 173(4): 2669 - 2674.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. M. Lynch, D. E. Briles, and D. W. Metzger
Increased Protection against Pneumococcal Disease by Mucosal Administration of Conjugate Vaccine plus Interleukin-12
Infect. Immun., August 1, 2003; 71(8): 4780 - 4788.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Djilali-Saiah, P. Lapierre, S. Vittozi, and F. Alvarez
DNA Vaccination Breaks Tolerance for a Neo-Self Antigen in Liver: A Transgenic Murine Model of Autoimmune Hepatitis
J. Immunol., November 1, 2002; 169(9): 4889 - 4896.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Velupillai, J. P. Carroll, and T. L. Benjamin
Susceptibility to Polyomavirus-Induced Tumors in Inbred Mice: Role of Innate Immune Responses
J. Virol., August 28, 2002; 76(19): 9657 - 9663.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Paludan, K. Bickham, S. Nikiforow, M. L. Tsang, K. Goodman, W. A. Hanekom, J.-F. Fonteneau, S. Stevanovic, and C. Munz
Epstein-Barr Nuclear Antigen 1-Specific CD4+ Th1 Cells Kill Burkitt's Lymphoma Cells
J. Immunol., August 1, 2002; 169(3): 1593 - 1603.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. L. Refici, D. W. Metzger, B. P. Arulanandam, M. R. Lennartz, and D. J. Loegering
Fc{gamma}-receptor signaling augments the LPS-stimulated increase in serum tumor necrosis factor-{alpha} levels
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2001; 280(4): R1037 - R1044.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. P. Arulanandam, R. H. Raeder, J. G. Nedrud, D. J. Bucher, J. Le, and D. W. Metzger
IgA Immunodeficiency Leads to Inadequate Th Cell Priming and Increased Susceptibility to Influenza Virus Infection
J. Immunol., January 1, 2001; 166(1): 226 - 231.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.